Trypanosoma brucei CTP synthetase: A target for the treatment of African sleeping sickness
The drugs in clinical use against African sleeping sickness are toxic, costly, or inefficient. We show that Trypanosoma brucei, which causes this disease, has very low levels of CTP, which are due to a limited capacity for de novo synthesis and the lack of salvage pathways. The CTP synthetase inhibi...
Na minha lista:
| Publicado no: | Proc Natl Acad Sci U S A |
|---|---|
| Principais autores: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
National Academy of Sciences
2001
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC33482/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11353848/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.111139498 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
